NCT03233295View on ClinicalTrials.gov

A Prospective, Single-centre, Open-label Study to Confirm the Efficacy and Safety of Vitamin D3 B.O.N. Intramuscular Injection in Adults With Vitamin D Deficiency

PHASE4CompletedINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

October 23, 2014

Primary Completion Date

August 27, 2016

Study Completion Date

August 27, 2016

Conditions
Vitamin D Deficiency
Interventions
DRUG

Vitamin D3 B.O.N. Injection

cholecalciferol 200,000IU

All Listed Sponsors
lead

Kwang Dong Pharmaceutical co., ltd.

INDUSTRY

NCT03233295 - A Prospective, Single-centre, Open-label Study to Confirm the Efficacy and Safety of Vitamin D3 B.O.N. Intramuscular Injection in Adults With Vitamin D Deficiency | Biotech Hunter | Biotech Hunter